Cargando…

Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients

Background: Prostate cancer (PCa) is known to exhibit a wide spectrum of aggressiveness and relatively high immunogenicity. The aim of this study was to examine the effect of tumor excision on immunophenotype rearrangements in peripheral blood and to elucidate if it is associated with biochemical re...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosas, Paulius, Zaleskis, Gintaras, Dabkevičiene, Daiva, Dobrovolskiene, Neringa, Mlynska, Agata, Tikuišis, Renatas, Ulys, Albertas, Pašukoniene, Vita, Jarmalaitė, Sonata, Jankevičius, Feliksas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396861/
https://www.ncbi.nlm.nih.gov/pubmed/34442004
http://dx.doi.org/10.3390/jcm10163709
_version_ 1783744472271552512
author Bosas, Paulius
Zaleskis, Gintaras
Dabkevičiene, Daiva
Dobrovolskiene, Neringa
Mlynska, Agata
Tikuišis, Renatas
Ulys, Albertas
Pašukoniene, Vita
Jarmalaitė, Sonata
Jankevičius, Feliksas
author_facet Bosas, Paulius
Zaleskis, Gintaras
Dabkevičiene, Daiva
Dobrovolskiene, Neringa
Mlynska, Agata
Tikuišis, Renatas
Ulys, Albertas
Pašukoniene, Vita
Jarmalaitė, Sonata
Jankevičius, Feliksas
author_sort Bosas, Paulius
collection PubMed
description Background: Prostate cancer (PCa) is known to exhibit a wide spectrum of aggressiveness and relatively high immunogenicity. The aim of this study was to examine the effect of tumor excision on immunophenotype rearrangements in peripheral blood and to elucidate if it is associated with biochemical recurrence (BCR) in high risk (HR) and low risk (LR) patients. Methods: Radical prostatectomy (RP) was performed on 108 PCa stage pT2–pT3 patients. Preoperative vs. postoperative (one and three months) immunophenotype profile (T- and B-cell subsets, MDSC, NK, and T reg populations) was compared in peripheral blood of LR and HR groups. Results: The BCR-free survival difference was significant between the HR and LR groups. Postoperative PSA decay rate, defined as ePSA, was significantly slower in the HR group and predicted BCR at cut-off level ePSA = −2.0% d(−1) (AUC = 0.85 (95% CI, 0.78–0.90). Three months following tumor excision, the LR group exhibited a recovery of natural killer CD3 − CD16+ CD56+ cells, from 232 cells/µL to 317 cells/µL (p < 0.05), which was not detectable in the HR group. Prostatectomy also resulted in an increased CD8+ population in the LR group, mostly due to CD8+ CD69+ compartment (from 186 cells/µL before surgery to 196 cells/µL three months after, p < 001). The CD8+ CD69+ subset increase without total T cell increase was present in the HR group (p < 0.001). Tumor excision resulted in a myeloid-derived suppressor cell (MDSC) number increase from 12.4 cells/µL to 16.2 cells/µL in the HR group, and no change was detectable in LR patients (p = 0.12). An immune signature of postoperative recovery was more likely to occur in patients undergoing laparoscopic radical prostatectomy (LRP). Open RP (ORP) was associated with increased MDSC numbers (p = 0.002), whereas LRP was characterized by an immunity sparing profile, with no change in MDSC subset (p = 0.16). Conclusion: Tumor excision in prostate cancer patients results in two distinct patterns of immunophenotype rearrangement. The low-risk group is highly responsive, revealing postoperative restoration of T cells, NK cells, and CD8+ CD69+ numbers and the absence of suppressor MDSC increase. The high-risk group presented a limited response, accompanied by a suppressor MDSC increase and CD8+ CD69+ increase. The laparoscopic approach, unlike ORP, did not result in an MDSC increase in the postoperative period.
format Online
Article
Text
id pubmed-8396861
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83968612021-08-28 Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients Bosas, Paulius Zaleskis, Gintaras Dabkevičiene, Daiva Dobrovolskiene, Neringa Mlynska, Agata Tikuišis, Renatas Ulys, Albertas Pašukoniene, Vita Jarmalaitė, Sonata Jankevičius, Feliksas J Clin Med Article Background: Prostate cancer (PCa) is known to exhibit a wide spectrum of aggressiveness and relatively high immunogenicity. The aim of this study was to examine the effect of tumor excision on immunophenotype rearrangements in peripheral blood and to elucidate if it is associated with biochemical recurrence (BCR) in high risk (HR) and low risk (LR) patients. Methods: Radical prostatectomy (RP) was performed on 108 PCa stage pT2–pT3 patients. Preoperative vs. postoperative (one and three months) immunophenotype profile (T- and B-cell subsets, MDSC, NK, and T reg populations) was compared in peripheral blood of LR and HR groups. Results: The BCR-free survival difference was significant between the HR and LR groups. Postoperative PSA decay rate, defined as ePSA, was significantly slower in the HR group and predicted BCR at cut-off level ePSA = −2.0% d(−1) (AUC = 0.85 (95% CI, 0.78–0.90). Three months following tumor excision, the LR group exhibited a recovery of natural killer CD3 − CD16+ CD56+ cells, from 232 cells/µL to 317 cells/µL (p < 0.05), which was not detectable in the HR group. Prostatectomy also resulted in an increased CD8+ population in the LR group, mostly due to CD8+ CD69+ compartment (from 186 cells/µL before surgery to 196 cells/µL three months after, p < 001). The CD8+ CD69+ subset increase without total T cell increase was present in the HR group (p < 0.001). Tumor excision resulted in a myeloid-derived suppressor cell (MDSC) number increase from 12.4 cells/µL to 16.2 cells/µL in the HR group, and no change was detectable in LR patients (p = 0.12). An immune signature of postoperative recovery was more likely to occur in patients undergoing laparoscopic radical prostatectomy (LRP). Open RP (ORP) was associated with increased MDSC numbers (p = 0.002), whereas LRP was characterized by an immunity sparing profile, with no change in MDSC subset (p = 0.16). Conclusion: Tumor excision in prostate cancer patients results in two distinct patterns of immunophenotype rearrangement. The low-risk group is highly responsive, revealing postoperative restoration of T cells, NK cells, and CD8+ CD69+ numbers and the absence of suppressor MDSC increase. The high-risk group presented a limited response, accompanied by a suppressor MDSC increase and CD8+ CD69+ increase. The laparoscopic approach, unlike ORP, did not result in an MDSC increase in the postoperative period. MDPI 2021-08-20 /pmc/articles/PMC8396861/ /pubmed/34442004 http://dx.doi.org/10.3390/jcm10163709 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bosas, Paulius
Zaleskis, Gintaras
Dabkevičiene, Daiva
Dobrovolskiene, Neringa
Mlynska, Agata
Tikuišis, Renatas
Ulys, Albertas
Pašukoniene, Vita
Jarmalaitė, Sonata
Jankevičius, Feliksas
Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients
title Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients
title_full Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients
title_fullStr Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients
title_full_unstemmed Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients
title_short Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients
title_sort immunophenotype rearrangement in response to tumor excision may be related to the risk of biochemical recurrence in prostate cancer patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396861/
https://www.ncbi.nlm.nih.gov/pubmed/34442004
http://dx.doi.org/10.3390/jcm10163709
work_keys_str_mv AT bosaspaulius immunophenotyperearrangementinresponsetotumorexcisionmayberelatedtotheriskofbiochemicalrecurrenceinprostatecancerpatients
AT zaleskisgintaras immunophenotyperearrangementinresponsetotumorexcisionmayberelatedtotheriskofbiochemicalrecurrenceinprostatecancerpatients
AT dabkevicienedaiva immunophenotyperearrangementinresponsetotumorexcisionmayberelatedtotheriskofbiochemicalrecurrenceinprostatecancerpatients
AT dobrovolskieneneringa immunophenotyperearrangementinresponsetotumorexcisionmayberelatedtotheriskofbiochemicalrecurrenceinprostatecancerpatients
AT mlynskaagata immunophenotyperearrangementinresponsetotumorexcisionmayberelatedtotheriskofbiochemicalrecurrenceinprostatecancerpatients
AT tikuisisrenatas immunophenotyperearrangementinresponsetotumorexcisionmayberelatedtotheriskofbiochemicalrecurrenceinprostatecancerpatients
AT ulysalbertas immunophenotyperearrangementinresponsetotumorexcisionmayberelatedtotheriskofbiochemicalrecurrenceinprostatecancerpatients
AT pasukonienevita immunophenotyperearrangementinresponsetotumorexcisionmayberelatedtotheriskofbiochemicalrecurrenceinprostatecancerpatients
AT jarmalaitesonata immunophenotyperearrangementinresponsetotumorexcisionmayberelatedtotheriskofbiochemicalrecurrenceinprostatecancerpatients
AT jankeviciusfeliksas immunophenotyperearrangementinresponsetotumorexcisionmayberelatedtotheriskofbiochemicalrecurrenceinprostatecancerpatients